Skip to content
lifestyle.brickvest.com
Animals
Auto
Beauty & Style
Business News
Entertainment
Food
Health
Home & Family
Podcasts
Tech
Travel
Author:
Olema Oncology
Olema Oncology to Present Preclinical Data for Palazestrant and OP-3136 at the 2026 AACR Annual Meeting
May 17, 2026
Olema Oncology Reports Fourth Quarter and Full Year 2025 Financial and Operating Results
May 17, 2026
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 3, 2026
Olema Oncology Announces Departure of Chief Operating and Financial Officer
January 30, 2026
←
Previous Page
1
2